Clinical Trials
2 trialsNCT00003245 2018-11-15
Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00005626 2012-09-25
Phase II Trial With Correlative Laboratory Studies of Single Agent Irinotecan (Camptosar CPT-11)
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed